Hunan Er Kang Pharmaceutical Cash Flow-to-Debt Ratio
Hunan Er Kang Pharmaceutical cash flow-to-debt ratio. Hunan Er Kang Pharmaceutical (300267) has a Cash Flow-to-Debt Ratio of 0.36x as of June 2023, meaning its operating cash flow of CN¥174.55 Million could theoretically repay 0% of its total liabilities (CN¥490.30 Million) in one year. Check Hunan Er Kang Pharmaceutical earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Hunan Er Kang Pharmaceutical (2008–2024)
Cash flow-to-debt ratio of Hunan Er Kang Pharmaceutical from 2008 to 2024. Historical debt coverage capacity for Hunan Er Kang Pharmaceutical across 17 annual periods. Check 300267 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Hunan Er Kang Pharmaceutical Cash Flow-to-Debt Ratio by Year (2008–2024)
Hunan Er Kang Pharmaceutical cash flow-to-debt ratio by year from 2008 to 2024. Year-by-year debt coverage analysis for Hunan Er Kang Pharmaceutical. For the full cash flow conversion analysis, see cash flow conversion of Hunan Er Kang Pharmaceutical.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.21x | CN¥166.69 Million | CN¥797.54 Million | ▼ -5.8% |
| 2023 | 0.22x | CN¥148.42 Million | CN¥669.05 Million | ▼ -36.5% |
| 2022 | 0.35x | CN¥281.02 Million | CN¥804.57 Million | ▲ +110.4% |
| 2021 | 0.17x | CN¥92.68 Million | CN¥558.28 Million | ▼ -30.0% |
| 2020 | 0.24x | CN¥178.53 Million | CN¥753.22 Million | ▼ -81.4% |
| 2019 | 1.27x | CN¥445.82 Million | CN¥350.72 Million | ▲ +320.0% |
| 2018 | 0.30x | CN¥123.89 Million | CN¥409.39 Million | ▼ -86.5% |
| 2017 | 2.23x | CN¥689.11 Million | CN¥308.37 Million | ▲ +87.8% |
| 2016 | 1.19x | CN¥486.50 Million | CN¥408.94 Million | ▲ +24.7% |
| 2015 | 0.95x | CN¥518.96 Million | CN¥544.10 Million | ▲ +195.1% |
| 2014 | 0.32x | CN¥175.38 Million | CN¥542.64 Million | ▼ -79.0% |
| 2013 | 1.54x | CN¥174.22 Million | CN¥113.01 Million | ▲ +34.5% |
| 2012 | 1.15x | CN¥84.02 Million | CN¥73.32 Million | ▼ -0.3% |
| 2011 | 1.15x | CN¥75.72 Million | CN¥65.90 Million | ▲ +222.3% |
| 2010 | 0.36x | CN¥42.47 Million | CN¥119.15 Million | ▲ +165.1% |
| 2009 | 0.13x | CN¥10.18 Million | CN¥75.72 Million | ▲ +3682.9% |
| 2008 | 0.00x | CN¥211.00K | CN¥59.37 Million | — |